Brief: BioRestorative, Galen Patient Recruitment Partner To Accelerate Enrollment Completion In Mid-Stage Trial of Therapy To Treat Chronic Lumbar Disc Disease
April 8 (Reuters) - BioRestorative Therapies Inc
BRTX.O :
* BIORESTORATIVE THERAPIES PARTNERS WITH GALEN PATIENT
RECRUITMENT
TO ACCELERATE COMPLETION OF ENROLLMENT IN PHASE 2 TRIAL OF
BRTX-100 IN CHRONIC LUMBAR DISC DISEASE
* BIORESTORATIVE THERAPIES INC - PATIENT ENROLLMENT EXPECTED
TO BE
COMPLETED IN 2024
Source text for Eikon: ID:nGNX5tmHlV
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM